In many cases these results are robust, as several studies showed the same up- or down-regulation for the CK2 transcript (e.g. up to 4 studies for CK2α and CK2β increase in hepatocellular carcinoma) (Table 18). The gene discussed is CSNK2B; the disease is hepatocellular carcinoma.